Review



recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12  (ImClone Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    ImClone Inc recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Recombinant Human Igg1 Monoclonal Antibody Cixutumumab Formerly Imc A12, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc09955633-107-0-8
    Average 90 stars, based on 1 article reviews
    recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12 - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma"

    Article Title: Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma

    Journal: Current Oncology

    doi: 10.3390/curroncol30020105

    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Figure Legend Snippet: Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.

    Techniques Used: Clinical Proteomics, Virus, Infection



    Similar Products

    90
    ImClone Inc recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Recombinant Human Igg1 Monoclonal Antibody Cixutumumab Formerly Imc A12, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc09955633-107-0-8
    Average 90 stars, based on 1 article reviews
    recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    ImClone Inc cixutumumab imc-a12 antibody
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Cixutumumab Imc A12 Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc07290707-59-4-5
    Average 90 stars, based on 1 article reviews
    cixutumumab imc-a12 antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Novartis monoclonal antibody imc-a12
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Monoclonal Antibody Imc A12, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/monoclonal+antibody+imc+a12/pm31731883-193-24-33
    Average 90 stars, based on 1 article reviews
    monoclonal antibody imc-a12 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    ImClone Inc imc-a12 cixutumumab antibody
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Imc A12 Cixutumumab Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/anti+igf+1r+monoclonal+antibody+a12/pm31731883-155-7-13
    Average 90 stars, based on 1 article reviews
    imc-a12 cixutumumab antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    ImClone Inc imc-a12 antibody
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Imc A12 Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc06245538-46-0-11
    Average 90 stars, based on 1 article reviews
    imc-a12 antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly cixutumumab imc-a12 antibody
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Cixutumumab Imc A12 Antibody, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/cixutumumab/us09931402-154-21-23
    Average 90 stars, based on 1 article reviews
    cixutumumab imc-a12 antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    ImClone Inc cixutumumab (imc-a12) antibody
    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
    Cixutumumab (Imc A12) Antibody, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pm28374141-47-0-2
    Average 90 stars, based on 1 article reviews
    cixutumumab (imc-a12) antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.

    Journal: Current Oncology

    Article Title: Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma

    doi: 10.3390/curroncol30020105

    Figure Lengend Snippet: Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.

    Article Snippet: Recombinant human IgG1 monoclonal antibody cixutumumab (formerly IMC-A12, ImClone Systems, Inc, Bridgewater, NJ, USA) is aimed at IGF-1R.

    Techniques: Clinical Proteomics, Virus, Infection